2023 Contraceptive Social Marketing Statistics Report

Publication date: 2024

� �� � � Published June 2024 2023 Contraceptive Social Marketing Statistics Report https://www.linkedin.com/company/reproductive-health-supplies-coalition/ https://www.facebook.com/rhsupplies https://twitter.com/rh_supplies https://www.youtube.com/@rhsupplies https://medium.com/its-about-supplies 1 The Contraceptive Social Marketing Statistics (CSM) Report is a tool that aims to provide the global sexual and reproductive health (SRH) community with accurate data that can support the healthy development of a market in constant evolution. The CSM Report aggregates sales data from social marketing organizations (SMOs) operating around the globe to expand access to critical family planning commodities and safe abortion supplies. Social marketing programs typically sell these products to the private sector (including clinics, supermarkets, mini-markets, and other shops), but some programs also make sales to non-governmental organizations (NGOs) and/or to the public sector. For over three decades, the CSM Report has complemented public health data by providing unique insight into SMOs’ contributions to global SRH markets. After over 30 years of tremendous work in compiling social marketing statistics, DKT International has handed over the development and publication of this important resource to the Reproductive Health Supplies Coalition (RHSC). RHSC is grateful to DKT for their leadership on the CSM Report and continued partnership in the years to come. RHSC assumes this responsibility with an eagerness to maintain the landmarks of previous editions and broaden the impact of the report by listening to the SRH community with regards to the report’s utility and ways they would like to see the report adapted, expanded, or clarified in the future. This process began last year with consultations with the different social marketing organizations that make this report possible and was expanded at the RHSC General Membership Meeting, where a co-creation session on the future of the CSM Report was held. Finally, an advisory group (AG) was established to guide the development of the user-informed design process and strategic approach for the report. The RHSC looks forward to continued engagement with the community throughout the years on this essential and collaborative effort. The Contraceptive Social Marketing Statistics Report is a respected community data resource. RSHC is very proud to take over the production and dissemination of this key report, building on 30 years of work by DKT International, a member organization of RHSC. This is in keeping with RHSC’s long history of promoting data visibility and use within the community and the move has been welcomed by the reproductive health community as a timely and unique addition to the canon of RH data resources we already produce. The Coalition has commissioned, produced, and disseminated key data across the RH supplies ecosystem, including the management of the Global Family Planning Data Visibility and Analytics Network (VAN), the Family Planning Market Report, the Landscape and Projection of Reproductive Health Supply Needs Report (LEAP), and many others. Through our vast network of members spanning governments, private sector partners, manufacturers, procurers, donor organizations, and civil society and advocacy organizations, RHSC is well-positioned to ensure that the data platforms, tools, and resources we produce are responsive to the needs of our members. We recognize that the needs of the community are in constant flux as new products and stakeholders enter the equation, sometimes changing the ecosystem. Looking ahead, RHSC views a unique opportunity to ensure that the CSM Report remains fit for purpose and provides the maximum value to members as an important data tool. To do this, the Coalition recognizes the need to better understand the ways in which the CSM Report is used by members, where members have faced difficulties or challenges with the report, and how members hope to see the report evolve in the future. And, in keeping with our role as a membership organization, we gathered forward- looking feedback from the community and called on the support of key partners over the last year. Report Explanation DIRECTOR’S NOTE https://www.rhsupplies.org/news-events/news/rhsc-to-produce-contraceptive-social-marketing-report-1826/ 2 We started this consultation process in 2023 through a series of user-informed design activities. First, we conducted consultations with many of the SMOs in order to better understand their experiences in reporting sales data. Second, during our 2023 General Membership Meeting in Accra, Ghana we hosted a Co-Creation Session with members in attendance around the future of the CSM Report, where we asked members (1) how they have used the CSM Report in the past; (2) what they found most valuable about the report; (3) how the report could be improved; and (4) what challenges they have had with the report. These two activities gave us initial insight into the community's use of, and experience with, the report and laid the groundwork for the establishment of an Advisory Group (AG) to provide guidance throughout this process. In early 2024, we launched the AG, a multisectoral group of RHSC members who have come together to consider some of the key questions that underpin the future of the CSM Report and advise on a pathway forward. In particular, the AG was convened to: 1. Develop a long-term strategy and set of priorities for the future vision of the CSM Report, including recommendations around a user-informed design process; 2. Serve as a consultative body and make recommendations around shifts in definitions, scope, and analyses included in future iterations of the CSM Report; 3. Make recommendations around minor adjustments, where needed, in the 2023 CSM Report. Since March, the AG has come together to inform initial recommendations and to outline next steps. And, in the year ahead, the AG will continue to convene regularly to guide the user-informed design process outlined in Annex 1. Through these conversations with community members, we opted to keep this year’s version of the CSM Report more or less status quo, to allow comparisons to the past and time to figure out, through forward- looking reviews and the AG, what changes should accompany future versions of the report. We are indebted to our AG who informed the planning and production of this issue of the CSM Report. The transition of the CSM Report to RHSC further strengthens our collective understanding of the global RH supply data landscape and where the gaps are, and we look forward to building those learnings back into strengthening and developing our data outputs. We can promise that the next iteration of the CSM report—to be published in 2025—will build further on the rich history and strong foundation we have inherited from DKT and our community can expect continual improvement in coverage and insights. We welcome your thoughts and appreciate your engagement, Martyn Smith RHSC https://www.rhsupplies.org/news-events/news/co-creating-the-future-of-the-csm-report-1832/ https://www.rhsupplies.org/news-events/news/co-creating-the-future-of-the-csm-report-1832/ 3 Changes from Previous Years In the coming years, RHSC is eager to engage its members and stakeholders across sectors to improve the report’s utility within the SRH data landscape. For this initial year of developing and publishing the CSM Report, RHSC has decided to maintain a certain level of status quo, both to make the transition as manageable as possible for users and participating organizations, and to provide sufficient time to engage with the AG and report stakeholders to obtain feedback, input, and concerns from the community. Nonetheless, there are some minor changes made to the report in this first year that the Coalition and AG determined to be a valuable first step in a series of improvements that will reflect the viewpoints of the consulted organizations and individuals. The first change is the inclusion of the USAID Couple Years of Protection (CYP) conversion factors as an additional datapoint alongside the conversion factors used in previous years. This addition is intended to make the data more usable and comparable, as the USAID CYP conversion factors tend to be more widely used among the broader community and are reflected in other data sources. This change will also apply to the analyses contained within the CSM Report. At this stage, RHSC has updated the most recent three years of data for use in the report analyses, but has not yet updated the older historical data file, as we seek feedback on the usefulness of a full update. Since USAID conversion factors do not include safe abortion supplies, there is no additional USAID factor provided for these products. In these cases, the original conversion factor is still available. In future years, a comparable impact metric for safe abortion supplies will be explored with the AG. The second change is the removal of the 10,000 CYPs threshold required for country programs to be included in the CSM Report. Consultation with users found very consistent feedback about the high value of sales data – regardless of CYPs generated – as sales data provides crucial insights into the total market. This understanding of market dynamics and opportunity is one of the primary uses of the report according to the information collected thus far from the community. Consequently, for the 2023 CSM Report, there is no minimum CYP requirement for inclusion and all reporting SMOs are included. RHSC and the AG also wanted to ensure that the 10,000 CYP threshold did not act as a barrier to participation for smaller and independent SMOs. The third and final change is related to product categories. RHSC is acutely aware that different factors, like market and technological innovations, have resulted in changes and additions to product categories throughout the years. As product categories continue to evolve, and more contraceptives and safe abortion supplies are made available globally, the Coalition wants to ensure that the report can provide key insights into these categories. For the 2023 CSM Report, the Oral Contraceptive Pill (OCP) category will be split into two new categories: Combined Oral Contraceptives (COC) and Progestin- Only Pills (POP). Similarly, IUDs will be split into two categories: Hormonal IUD and Non-Hormonal IUDs. These category changes follow the addition of the USAID CYP conversion factors for these products and will provide more specific data for the report. Given the Coalition’s data stewardship related to contraceptive product mapping and master data management through VAN and LEAP, in the coming year, the AG will consider important changes to the product category structure, with a focus on comparability across data sets, and seek input from the broader community to inform future changes. To get more details on the rationale and the processes that are taking place to develop the user-informed design for the CSM Report, please see Annex 1 at the end of the report. PHARMACY 4 How Do We Calculate CYPs? 1 USAID. Couple-Years of Protection (CYP). Accessed via https://www.usaid.gov/global-health/health-areas/family-planning/couple-years-protection-cyp. 2 DKT International. Resources. Accessed via https://www.dktinternational.org/resources/. Couple Years of Protection, Couple Years of Protection, or CYPs, are a common sexual and reproductive health metric representing the amount of contraception one couple needs to prevent pregnancy over a 1-year period. CYP conversion factors are based on the expected amount of time a product can be used before replacement, thus determining the number of years of protection a couple has from a given contraceptive method. As mentioned in the changes from previous years, the 2023 CSM Report will use two sets of CYP calculations for each of the product categories: the historical conversion factor retained from previous iterations of the CSM Report, and the USAID conversion factor. It is also worth noting that some rows in the CYP chart below are intentionally left blank when there is not a conversion factor for a given product (e.g. there is no USAID CYP factor for safe abortion supplies). For more information about USAID CYP calculations and rationale, please visit USAID’s website.1 For a more information on the CYP calculations and rationale from previous CSM Reports please visit DKT’s website or reference previous CSM Reports in the ‘How Do We Calculate CYPs’ section.2 DATA DISCLAIMERS All sales data in this report is self-reported and it was not always possible to differentiate between sales to the private sector and sales to other NGOs or the public sector. RHSC also recognizes that there are limitations in ensuring that all SMOs operating in this space worldwide are represented within the CSM Report. There is no comprehensive list of all SMOs that are currently active, so there may be SMOs that were not included in the process of developing the 2023 CSM Report, and some organizations opted out of reporting their data. Data from clinical services is not included in this report. For many of the DKT programs included in the report, the sales data includes both sales to the private sector as well as sales to NGOs or the public sector. In consultation with DKT International, CYP totals are adjusted to discount the CYP totals in order to account for the sales to the public sector and NGOs. If you would like to be included in future reporting, or have additional suggestions of SMOs we should include, please contact csmreport@rhsupplies.org. RHSC is eager to continue to increase the number of SMOs reporting sales data to better reflect this part of the market. METHOD HISTORICAL* USAID Condoms 100 0.00833 Free Condoms 200 0.00833 Female Condoms 100 0.00833 Free Female Condoms 200 0.00833 Combined Oral Contraceptives (COC) 14 0.0667 Progestin-only Pills (POP) 14 0.0833 Injectable (1 mo) 12 0.077 Injectable (2 mo) 6 0.167 Injectable (3 mo) 4 0.25 Hormonal IUDs 4.4 4.6 Non-hormonal IUDs 4.4 4.8 Implants (3 year) 2.5 2.5 Implants (4 year) 3.2 — Implants (5 year) 3.8 3.8 Emergency Contraception 16 0.05 Medical Abortion (MA) Combipack** 1.7 — Misoprostol (Miso) Tablets 12 — Mifepristone Tablets 0.67 — Manual Vacuum Aspiration (MVA) Kit 25 — MVA Single 25 — Aspirator 25 — Vaginal Foaming Tablets 120 0.00833 Vaginal Contraceptive Film 120 — Diaphragm 1 1 Conversion factors * Historical Conversion Factor (Past & Current CSM Reports) ** 1 Mifepristone + 4 Misoprostol tabletsPHARMACY https://www.usaid.gov/global-health/health-areas/family-planning/couple-years-protection-cyp https://www.dktinternational.org/resources/ https://www.usaid.gov/global-health/health-areas/family-planning/couple-years-protection-cyp https://www.dktinternational.org/resources/ mailto:csmreport%40rhsupplies.org?subject= 5 Social Marketing Statistics 2023 S A LE S - 2 02 3 H IG H LI G H TS : C YP T R EN D S - 2 02 0- 20 23 Condoms 1,300,713,175 98 programs Free Condoms 1,358,488 1 program Female Condoms 858,015 12 programs Free Female Condoms 13,000 1 program Combined IUDs (Non-Hormonal + Hormonal) 6,037,398 69 programs Combined Implants 664,370 45 programs Combined Injectables 44,253,507 63 programs Oral Contraceptives (POP & COC) 206,241,228 53 programs Emergency Contraception (EC) 39,029,596 70 programs Manual Vacuum Aspiration (MVA) kits 73,436 39 programs Aspirators 29,091 16 programs Cannulae 290,362 21 programs Misoprostol Tablets 37,612,124 55 programs Mifepristone Tablets 551,285 5 programs MA ‘Combipack’ (Mifepristone + Misoprostol) 6,985,101 44 programs Diaphragms 2,284 5 programs MVA Singles 11,576 3 programs HISTORICAL USAID 2020 84.8 million 60.9 million 2021 78.1 million 59.6 million 2022 87 million 59.3 million 2023 81.6 million 60.9 million 40M 60M 80M 100M CYPs using Historical Conversion Factor CYPs using USAID Conversion Factor 2020 2021 2022 2023 CYPs generated by Social Marketing Organizations CYPs generated by Social Marketing Organizations Using the historical conversion factors, we see a 5.4 million reduction in CYPs from SMO sales between 2022 and 2023. Conversely, when using the USAID conversion factors, we see a modest increase of 1.6 million CYPs between 2022 and 2023. The CYP totals using the USAID conversion factors do not include CYPs generated from abortion commodities, accounting for the largest difference between the two sets of conversion factors. To that end, this difference in CYP trends between 2022 and 2023—and in particular, the decline in CYPs using the historical conversion factor—could, at least in part, be due to changes in sales of abortion commodities in 2023 (which would not be reflected in CYP totals using the USAID conversion factors). Across the four years depicted in the chart and graph to the right, the number of reporting programs remains relatively consistent, and thus likely wouldn’t account for the decline between 2022 and 2023. To better understand these trends, additional analysis of the sales data would be necessary. Historically, the CSM Report did not include this level of analysis, but as we look to future changes, we will explore opportunities to add additional analysis to sales and impact trends. 6 The work of the SMOs included in the CSM Report would not be possible without the generous support of many donors. Reporting SMOs thank the following donors for their contributions to their work: Abt Associates; Children's Investment Fund Foundation; the Gates Foundation); David and Lucile Packard Foundation; Embassy of the Kingdom of the Netherlands; UK Foreign, Commonwealth & Development Office (FCDO); Government of Germany (KfW Development Bank); Government of India; International Organization for Migration (OIM); International Planned Parenthood Federation (IPPF); KfW Development Bank; Mylan; Planned Parenthood Federation of America records (PPFA-I); President's Emergency Plan for AIDS Relief (PEPFAR); Swedish International Development Agency; The Erik. E. and Edith H. Bergstrom Foundation; The Global Fund; The U.S. President's Emergency Plan for AIDS Relief (PEPFAR); UNFPA Albania; United Nations Office for Project Services (UNOPS); United Nations Population Fund (UNFPA); United States Agency for International Development (USAID); USAID SMC; West African Health Organization (WAHO); WestWind Foundation; William and Flora Hewlett Foundation, and countless anonymous donors. C YP s G EN ER AT ED B Y M O S T S O LD P R O D U C TS IN 2 02 3 PRODUCT CYPs % Condoms 12,788,730  16.56  Oral Contraceptives (COC + POP) 14,706,278  19.04  Combined Injectables 9,248,945  11.98  Emergency Contraception 2,423,888  3.14  Misoprostol Tablets (Miso) 3,122,482  4.04  Combined IUDs (Non-Hormonal + Hormonal) 23,119,248  29.94  MA ‘Combipack’ (Mifepristone Tablets-Misoprostol) 11,819,723  15.30  Total 77,229,294  100.0  PRODUCT CYPs % Condoms 10,659,058  17.83  Oral Contraceptives (COC + POP) 13,785,461  23.06  Combined Injectables 9,202,977  15.40  Emergency Contraception 1,939,110  3.24  Combined IUDs (Non-Hormonal + Hormonal) 24,174,849  40.44  Free Condoms 11,316  0.02  Female Condoms 4,171  0.01  Total 59,776,942  100.00  HISTORICAL CONVERSION FACTOR USAID CONVERSION FACTOR 16.56% 19.04% 11.98% 3.14%4.04% 29.94% 15.30% 17.83% 23.06% 15.40% 3.24% 40.44% 0.2% 0.01% DONOR ACKNOWLEDGMENTS 7 AIMAS . Agence Ivoirienne de Marketing Social ANIMAS SUTURA . Nigerian Association of Social Marketing ASHONPLAFA . Asociación Hondureña de Planificación Familiar ASMO . Afghan Social Marketing Organization CEMOPLAF .Centro Médico de Orientación y Planificación Familiar CIES Salud Sexual - Salud Reproductiva .Centro de Investigación y Educación Sexual y Reproductiva: Salud Sexual - Salud Reproductiva DKT . DKT International FHS .Family Health Services FPA .Sri Lanka Family Planning Association of Sri Lanka MPHD .Momentum Private Health Delivery MSI .MSI Reproductive Choices Nepal CRS Company .Nepal Contraceptive Retail Sales OCEAC . Organization for Coordinating the Fight Against Endemics in Central Africa PPSAC .Project for the Prevention of HIV/AIDS in Central Africa PROMACO .Programme de Marketing Social et de Communication pour la Santé PSI .Population Services International PSK .Population Services Kenya PSH . Population Solutions for Health (Zimbabwe) SFH . Society for Family Health (Rwanda) SLaDA . Sierra Leone Social Marketing and Development Agency SMC . Social Marketing Company (Bangladesh) TFHO . Total Family Health Organization T-MARC . Tanzania Marketing and Communications Project USAID . United States Agency for International Development ORGANIZATION ACRONYMS Social Marketing Program Sales Sales data and statistics listed for all reporting programs PROGRAM INFORMATION SOURCE PRODUCT SALES CYPs (HISTORICAL) CYPs (USAID) 1. Afghanistan (1) Started by the Communication for Behavior Change; Expanding Access to Private Sector Health Project and Services in Afghanistan (COMPRI-A) Project ASMO Condoms . 3,843,180 Injectables (1) . 252,695 Combined Oral Contraceptives (COC) . 661,012 Progestin-only Pills (POP) . 75,987 Total 38,432 21,058 47,215 5,428 1112,133 32,014 19,458 44,090 6,330 101,890 2. Afghanistan (2) Started by DKT in 2020 DKT Condoms . 2,001,072 Non-hormonal IUDs . 112,700 Implants (3) . 1,750 Injectables (3) . 108,000 Combined Oral Contraceptives (COC) . 225,000 Emergency Contraception . 92,000 MVA . 1,740 Misoprostol . 358,000 Total 20,011 495,880 4,375 27,000 16,071 5,750 43,500 29,833 642,420 16,669 518,420 4,375 27,000 15,008 4,600 — — 586,071 8 PROGRAM INFORMATION SOURCE PRODUCT SALES CYPs (HISTORICAL) CYPs (USAID) 3. Afghanistan (3) Started by MSI in 2003 MSI Condoms . 1,351,455 Non-hormonal IUDs . 33,680 Implants (5) . 596 Combined Oral Contraceptives (COC) . 149,985 Emergency contraception . 1,173 Total 13,515 148,192 2,265 10,713 73 174,758 11,258 154,928 2,265 10,004 59 178,513 4. Albania Nesmark Foundation Condoms . 119,304 Total 1,193 1,193 994 994 5. Argentina Started by DKT in 2018; Prior year results included in regional hub (DKT Latin America South (LAS) DKT Aspirators . 1,000 Cannulae . 10,000 Total 25,000 — 25,000 — — — 6. Bahrain DKT Non-hormonal IUDs . 800 Total 3,520 3,520 3,680 3,680 7. Bangladesh (1) Started by MSI in 1988 MSI MA ‘Combipack’ . 30,556 Total 51,945 51,945 — — 8. Bangladesh (2) Started by PSI in 1975; Now managed by the Social Marketing Company (formerly SMP) SMC Condoms . 164,104,880 Non-hormonal IUDs . 9,342 Implant (5) . 4,838 Injectables (3) . 5,312,626 Combined Oral Contraceptives (COC) . 42,326,826 Progestin-only Pills (POP) . 3,046,445 Total 1,641,049 41,105 18,384 1,328,157 3,023,345 217,603 6,269,642 1,366,994 42,973 18,384 1,328,157 2,823,199 253,769 5,833,476 9. Benin Started by DKT in 2017 DKT Condoms . 1,396,056 Non-hormonal IUDs . 5,190 Injectables (3) . 3,560 Combined Oral Contraceptives (COC) . 1,620 Emergency Contraception . 279,240 MVA kits. 900 Misoprostol . 313,920 MA ‘Combipack’ . 5,860 Total 13,961 22,836 890 116 17,453 22,500 26,160 9,962 113,877 11,629 23,874 890 108 13,962 — — — 50,463 10. Bolivia (1) Started by CIES in 1987 CIES Salud Sexual - Salud Reproductiva Condoms . 104,036 Hormonal IUDs . 3,173 Non-hormonal IUDs . 3,979 Implants (3) . 5,371 Implants (5) . 5,452 Injectables (1) . 2,407 Injectables (3) . 2,340 Combined Oral Contraceptives (COC) . 4,211 Emergency Contraception . 702 Total 1,040 13,961 17,508 13,428 20,718 201 585 301 44 67,785 867 15,230 18,303 13,428 20,718 185 585 281 35 69,632 11. Bolivia (2) Started by DKT in 2017 DKT Condoms . 700,092 Female Condoms . 4,650 Non-hormonal IUDs . 10,832 Implants (3) . 2,316 Combined Oral Contraceptives (COC) . 2,820 Emergency Contraception . 37,220 Aspirators . 1,506 Cannulae . 14,015 Misoprostol . 7,584 MA ‘Combipack’ . 1,470 Diaphragm . 94 Total 7,001 47 47,661 5,790 201 2,326 37,650 — 632 2,499 94 103,901 5,832 39 49,827 5,790 188 1,861 — — — — 94 63,631 9 PROGRAM INFORMATION SOURCE PRODUCT SALES CYPs (HISTORICAL) CYPs (USAID) 12. Brazil Started by DKT in 1991; CYPs have been discounted DKT Condoms . 126,386,157 Non-hormonal IUDs . 231,180 Injectables (3) . 400 Aspirators . 11,309 Cannulae . 42,503 Diaphragm . 341 Total 1,263,862 734,045 100 282,725 — 341 2,281,073 1,052,797 767,411 100 — — 341 1,820,649 13. Burkina Faso (1) Started by DKT in 2016; CYPs have been discounted DKT Condoms . 2,179,080 Non-hormonal IUDs . 5,885 Injectables (3) . 7,060 Emergency Contraception . 57,670 MVA kits. 170 Misoprostol . 170,560 MA ‘Combipack’ . 10,980 Total 21,791 25,894 1,765 2,783 4,250 14,213 18,666 89,362 18,152 27,071 1,765 2,226 — — — 49,214 14. Burkina Faso (2) Started by MSI in 2009 MSI Condoms . 460,768 Injectables (3) . 25 Combined Oral Contraceptives (COC) . 63,981 Emergency Contraception . 5,854 Misoprostol . 363,040 MA ‘Combipack’ . 2,660 Total 4,608 6 4,570 366 30,253 4,522 44,325 3,838 6 4,268 293 — — 8,405 15. Burkina Faso (3) Started by Programme de marketing social et de communication pour la santé (PROMACO) PROMACO Condoms . 12,349,760 Free Condoms . 1,358,488 Female Condoms . 4,300 Free Female Condoms . 13,000 Total 123,498 6,792 43 65 130,398 102,874 11,316 36 108 114,334 16. Cambodia Started by MSI in 1998 MSI Condoms . 43 Non-hormonal IUDs . 225 Implants (3) . 550 Implants (5) . 72 Injectables (3) . 1,400 Combined Oral Contraceptives (COC) . 1,043 Emergency Contraception . 141 MA ‘Combipack’ . 642 Total 0 990 1,375 274 350 75 9 1,091 4,164 0 1,035 1,375 274 350 70 7 — 3,111 17. Cameroon Started by DKT in 2016 DKT Condoms . 8,691,696 Non-hormonal IUDs . 19,490 Implants (3) . 300 Combined Oral Contraceptives (COC) . 6,000 Emergency Contraception . 80,180 MVA kits. 2,894 Misoprostol . 404,880 MA ‘Combipack’ . 36,174 Total 86,917 85,756 750 429 5,011 72,350 33,740 61,496 346,449 72,402 89,654 750 400 4,009 — — — 167,215 18. Cameroon Started by OCEAC in 2006 PPSAC - OCEAC Condoms . 6,216,300 Total 62,163 62,163 51,782 51,782 19. Central African Republic Started by OCEAC in 2006 PPSAC - OCEAC Condoms . 2,326,320 Total 23,263 23,263 19,378 19,378 10 PROGRAM INFORMATION SOURCE PRODUCT SALES CYPs (HISTORICAL) CYPs (USAID) 20. Chad (1) DKT Condoms . 144,000 Non-hormonal IUDs . 1,800 Implants (3) . 30 Emergency Contraception . 5,405 MVA kits. 250 Misoprostol . 49,920 MA ‘Combipack’ . 960 Total 1,440 7,920 75 338 6,250 4,160 1,632 21,815 1,200 8,280 75 270 — — — 9,825 21. Chad (2) Started by OCEAC in 2006 PPSAC - OCEAC Condoms . 2,228,172 Total 22,282 22,282 18,561 18,561 22. Chile Started by DKT in 2010; CYPs have been discounted DKT Condoms . 674,404 Female Condoms . 704,000 Non-hormonal IUDs . 2,112 Implants (3) . 116 Injectables (3) . 2,921 Emergency Contraception . 38,939 Aspirators . 1,241 Cannulae . 1,738 Misoprostol . 9 MA ‘Combipack’ . 9 Total 6,744 3,520 9,293 290 730 2,434 31,025 — 1 15 54,052 5,618 2,932 9,715 290 730 1,947 — — — — 21,232 23. Colombia Started by DKT in 2017; CYPs have been discounted DKT Condoms . 534,600 Female Condoms . 4,400 Non-hormonal IUDs . 30,829 Aspirators . 1,573 Cannulae . 23,967 Diaphragm . 565 Total 5,346 44 76,811 39,325 — 565 122,091 4,453 37 80,302 — — 565 85,357 24. Congo / Brazzaville (1) Started by DKT in 2020 DKT Condoms . 189,822 Non-hormonal IUDs . 1,500 Implants (3) . 6,939 Implants (5) . 2,470 Injectables (3) . 1,104 Combined Oral Contraceptives (COC) . 1,283 Emergency Contraception . 872 MVA kits. 77 Misoprostol (tabs) . 23,800 MA ‘Combipack’ . 1,553 Total 1,898 6,600 17,348 9,386 276 92 55 1,925 1,983 2,640 42,202 1,581 6,900 17,348 9,386 276 86 44 — — — 35,620 25. Congo / Brazzaville (2) Started by OCEAC in 2009 PPSAC - OCEAC Condoms . 5,733,360 Total 57,334 57,334 47,759 47,759 26. Costa Rica Started by DKT in 2018 DKT Condoms . 882,724 Emergency Contraception . 600 Total 8,827 38 8,865 7,353 30 7,383 27. Côte d'Ivoire (1) Started by PSI in 1998; now managed by AIMAS AIMAS Condoms . 34,071,600 Injectables (3) . 169,490 Combined Oral Contraceptives (COC) .4,097,124 Emergency Contraception . 1,425,220 Total 340,716 42,373 292,652 89,076 764,816 283,816 42,373 273,278 71,261 670,728 11 PROGRAM INFORMATION SOURCE PRODUCT SALES CYPs (HISTORICAL) CYPs (USAID) 28. Côte d'Ivoire (2) Started by DKT in 2017; CYPs have been discounted DKT Condoms . 5,886,216 Non-hormonal IUDs . 24,428 Implants (3) . 30 Injectables (3) . 6,400 Emergency Contraception . 112,084 MVA kits. 3,112 Misoprostol . 852,848 Total 58,862 107,483 75 1,600 7,005 77,800 71,071 323,896 49,032 112,369 75 1,600 5,604 — — 168,680 29. Democratic Republic of Congo (Kinshasa) Started by DKT in 2009; CYPs have been discounted DKT Condoms . 26,046,150 Non-hormonal IUDs . 179,980 Implants (3) . 322,994 Implants (5) . 88,345 Injectables (3) . 741,271 Combined Oral Contraceptives (COC) . 1,026,154 Emergency Contraception . 2,252,720 MVA kits. 3,947 Misoprostol . 566,068 MA ‘Combipack’ . 108,325 Total 214,940 634,823 430,541 197,777 112,279 51,332 128,298 98,675 47,172 146,421 2,062,259 179,045 663,679 430,541 197,777 112,279 47,934 102,638 — — — 1,733,893 30. Dominican Republic Started by DKT in 2016 DKT Condoms . 122,899 Aspirators . 130 Cannulae . 2,630 Total 1,229 3,250 — 4,479 1,024 — — 1,024 31. Ecuador (1) Started by CEMOPLAF in 1974 CEMOPLAF Condoms . 138,000 Non-hormonal IUDs . 610 Implants (3) . 983 Implants (5) . 837 Injectables (1) . 6,804 Injectables (3) . 9,396 Combined Oral Contraceptives (COC) . 2,900 Emergency Contraception . 2,020 Misoprostol . 64,820 Total 1,380 2,684 2,458 3,181 567 2,349 207 126 5,402 18,353 1,150 2,806 2,458 3,181 524 2,349 193 101 — 12,761 32. Ecuador (2) Started by DKT in 2017 DKT Condoms . 321,596 Female Condoms . 2,285 Non-hormonal IUDs . 6,715 Implants (3) . 5,448 Injectables (3) . 8,352 Emergency Contraception . 51,920 Aspirators . 438 Cannulae . 9,248 Misoprostol . 40,280 Total 3,216 23 29,546 13,620 2,088 3,245 10,950 — 3,357 66,044 2,679 19 30,889 13,620 2,088 2,596 — — — 51,891 33. Egypt Started by DKT in 2004 DKT Condoms . 6,365,578 Non-hormonal IUDs . 397,797 Emergency Contraception . 669,438 MVA kits. 168 Cannulae . 78 Total 63,656 1,750,307 41,840 4,200 — 1,860,002 53,025 1,829,866 33,472 — — 1,916,363 34. El Salvador Started by DKT in 2016 DKT Condoms . 134,405 Non-hormonal IUDs . 1,503 Injectables (1) . 1,040 Emergency Contraception . 3,050 Aspirators . 265 Cannulae . 2,120 Total 1,344 6,613 87 191 6,625 — 14,860 1,120 6,914 80 153 — — 8,266 12 PROGRAM INFORMATION SOURCE PRODUCT SALES CYPs (HISTORICAL) CYPs (USAID) 35. Ethiopia (1) Started by DKT in 1990; CYPs have been discounted DKT Condoms . 32,667,408 Non-hormonal IUDs . 498,079 Implants (3) . 2,530 Injectables (3) . 5,122,650 Combined Oral Contraceptives (COC) . 5,234,751 Emergency Contraception . 4,741,480 MVA kits. 2,180 Cannulae . 4,360 MA ‘Combipack’ . 356,158 Total 326,674 1,971,548 6,325 955,663 373,911 296,343 54,500 — 605,469 4,590,431 272,120 2,061,163 6,325 955,663 349,158 237,074 — — — 3,881,502 36. Ethiopia (2) Started by MSI in 1991 MSI Injectables (3) . 12,050 Emergency Contraception . 3,635,716 MA ‘Combipack’ . 374,381 Total 3,013 227,232 636,448 866,692 3,013 181,786 — 184,798 37. Gabon Started by DKT in 2017 DKT Condoms . 179,712 Total 1,797 1,797 1,497 1,497 38. The Gambia DKT Condoms . 83,736 MVA kits. 6 Total 837 150 987 698 — 698 39. Ghana (1) Started by DKT in 2011 DKT Condoms . 19,405,412 Female Condoms . 1,188 Non-hormonal IUDs . 11,994 Implants (3) . 1,729 Implants (5) . 13,003 Injectables (1) . 4,376 Injectables (3) . 163,443 Combined Oral Contraceptives (COC) . 376,791 Emergency Contraception . 5,735,280 MVA kits. 1,315 Misoprostol . 165,168 MA ‘Combipack’ . 83,125 Total 194,054 12 52,774 4,323 49,411 365 40,861 26,914 358,455 32,875 13,764 141,313 915,119 161,647 10 55,172 4,323 49,411 337 40,861 25,132 286,764 — — — 623,657 40. Ghana (2) Started by MSI in 2006 MSI Condoms . 412,740 Emergency Contraception . 99,612 Misoprostol . 215,033 MA ‘Combipack’ . 68,320 Total 4,127 6,226 17,919 116,144 144,417 3,438 4,981 — — 8,419 41. Ghana (3) Started by PSI in 2016 TFHO - PSI Condoms . 5,168,868 Non-hormonal IUDs . 3,450 Implants (3) . 4,640 Implants (5) . 3,240 Injectables (3) . 754,705 Combined Oral Contraceptives (COC) . 3,946,500 Total 51,689 15,180 11,600 12,312 188,676 281,893 561,350 43,057 15,870 11,600 12,312 188,676 263,232 534,746 42. Guatemala Started by DKT in 2014 DKT Condoms . 1,424,864 Hormonal IUDs . 50 Non-hormonal IUDs . 2,500 Mifepristone . 1,830 Total 14,249 220 11,000 1,226 26,695 11,869 240 11,500 — 23,609 13 PROGRAM INFORMATION SOURCE PRODUCT SALES CYPs (HISTORICAL) CYPs (USAID) 43. Guinea Started by DKT in 2017 DKT Condoms . 2,058,264 Non-hormonal IUDs . 2,270 Injectables (3) . 4,600 Emergency Contraception . 7,224 MVA kits. 822 Misoprostol . 126,720 MA ‘Combipack’ . 1,660 Total 20,583 9,988 1,150 452 20,550 10,560 2,822 66,104 17,145 10,442 1,150 361 — — — 29,099 44. Guinea-Bissau Started by DKT in 2017 DKT Condoms . 95,040 MVA kits. 10 Misoprostol . 1,440 Total 950 250 120 1,320 792 — — 792 45. Honduras (1) Started by Ashonplafa in 1963 Ashonplafa Condoms . 419,393 Hormonal IUDs . 48 Non-hormonal IUDs . 7,134 Implants (3) . 3,017 Injectables (1) . 159,328 Injectables (3) . 144,386 Combined Oral Contraceptives (COC) . 1,422,144 Total 4,194 211 31,390 7,543 13,277 36,097 101,582 194,293 3,494 230 32,816 7,543 12,268 36,097 94,857 187,305 46. Honduras (2) Started by DKT in 2018 DKT Condoms . 54,980 Non-hormonal IUDs . 1,073 Emergency Contraception . 91,000 Aspirators . 355 Cannulae . 2,840 Misoprostol . 114,464 Total 550 4,721 5,688 8,875 — 9,539 29,372 458 4,936 4,550 — — — 9,944 47. India (1) Mumbai; Started by DKT in 1992; Managed by DKT India DKT Condoms . 95,461,316 Hormonal IUDs . 5,931 Non-hormonal IUDs . 421,089 Injectables (3) . 161,544 Combined Oral Contraceptives (COC) . 15,848,103 Emergency Contraception . 124,570 Aspirators . 896 Cannulae . 6,765 Misoprostol . 1,719,140 MA ‘Combipack’ .2,776,049 Total 954,613 26,096 1,852,792 40,386 1,132,007 7,786 22,400 — 143,262 4,719,283 8,898,625 795,193 28,469 1,937,009 40,386 1,057,068 6,229 — — — — 3,864,354 48. India (2) Janani; Started by DKT in 1996; Managed by Janani (DKT) DKT Condoms . 17,286,853 Non-hormonal IUDs . 51,968 Injectables (3) . 214,453 Combined Oral Contraceptives (COC) . 1,507,738 Emergency Contraception . 77,463 MVA kits. 484 Aspirators . 554 Cannulae . 184 Misoprostol . 1,106,832 MA ‘Combipack’ . 1,735,394 Total 172,869 228,659 53,613 107,696 4,841 12,100 13,850 — 92,236 2,950,170 3,636,034 143,999 239,053 53,613 100,566 3,873 — — — — — 541,105 49. India (3) Started by MSI/PHS Population Health Services in 1999 MSI Condoms . 4,500 Non-hormonal IUDs . 309,840 Injectables (3) . 278,109 Combined Oral Contraceptives (COC) . 11,205,548 Emergency contraception . 135,495 Misoprostol . 2,696,119 Total 45 1,363,296 69,527 800,396 8,468 224,677 2,466,410 37 1,425,264 69,527 747,410 6,775 — 2,249,014 14 PROGRAM INFORMATION SOURCE PRODUCT SALES CYPs (HISTORICAL) CYPs (USAID) 50. Indonesia Started by DKT in 1996; CYPs have been discounted DKT Condoms . 193,678,386 Non-hormonal IUDs . 833,333 Implants (3) . 10,916 Injectables (1) . 6,811,800 Injectables (2) . 2,033,100 Injectables (3) . 13,898,500 Combined Oral Contraceptives (COC) . 36,145,875 Emergency Contraception . 246,972 MVA kits. 911 Aspirators . 1,569 Cannulae . 23,255 Misoprostol . 239,800 Total 1,915,782 2,496,826 27,290 567,650 338,850 3,474,625 2,581,848 15,436 22,775 39,225 — 19,983 11,500,291 1,595,846 2,610,318 27,290 524,509 339,528 3,474,625 2,410,930 12,349 — — — — 10,995,395 51. Iraq Started by DKT in 2021 DKT Condoms . 2,304,000 Injectables (3) . 240,000 Combined Oral Contraceptives (COC) . 135,962 Emergency Contraception . 9,995 Total 23,040 60,000 9,712 625 93,376 19,192 60,000 9,069 500 88,761 52. Jordan Started by DKT in 2022 DKT Condoms . 260,675 Non-hormonal IUDs . 10,602 MVA kits. 2 Total 2,607 46,649 50 49,306 2,171 48,769 — 50,941 53. Kenya (1) Started by DKT in 2016; CYPs have been discounted DKT Condoms . 19,590,447 Hormonal IUDs . 170 Non-hormonal IUDs . 6,818 Implants (3) . 810 Injectables (3) . 977,115 Combined Oral Contraceptives (COC) . 6,630 Emergency Contraception . 330,877 MVA kits. 917 Misoprostol . 391,272 MA ‘Combipack’ . 63,225 Total 195,904 748 29,999 2,025 243,580 474 20,680 17,300 32,336 105,188 648,234 163,188 816 31,363 2,025 243,580 442 16,544 — — — 457,958 54. Kenya (2) Started by MSI in 1986 MSI Condoms . 1,936,920 Hormonal IUDs . 598 Non-hormonal IUDs . 1,196 Emergency Contraception . 22,754 Misoprostol . 270,420 MA ‘Combipack’ . 29,512 Total 19,369 2,631 5,262 1,422 22,535 50,170 101,390 16,135 2,870 5,502 1,138 — — 25,644 55. Kenya (3) Started by DKT and PSI in 1989; now managed by Population Services Kenya PSK - PSI Condoms . 24,288,628 Injectables (1) . 39,775 Combined Oral Contraceptives (COC) . 4,651,200 Total 242,886 3,315 332,229 578,429 202,324 3,063 310,235 515,622 56. Kingdom of Saudi Arabia Started by DKT in 2018 DKT Non-hormonal IUDs . 33,000 Total 145,200 145,200 151,800 151,800 15 PROGRAM INFORMATION SOURCE PRODUCT SALES CYPs (HISTORICAL) CYPs (USAID) 57. Liberia Started by DKT in 2018 DKT Condoms . 699,207 Non-hormonal IUDs . 35,259 Implants (3) . 10,890 Injectables (3) . 63,046 Combined Oral Contraceptives (COC) . 138,900 Emergency Contraception . 336,661 MVA kits. 3,805 Misoprostol . 255,160 MA ‘Combipack’ . 44,644 Total 6,992 155,140 27,225 15,762 9,921 21,041 95,125 21,263 75,895 428,364 5,824 162,191 27,225 15,762 9,265 16,833 — — — 237,100 58. Madagascar Started by MSI in 1992 MSI Condoms . 69,853 Emergency Contraception . 1,865 Misoprostol . 290,543 Total 699 117 24,212 25,027 582 93 — 675 59. Malawi (1) Started by PSI in 1994; Now managed by Family Health Services (FHS) FHS - PSI Condoms . 8,246,448 Female Condoms . 47,605 Hormonal IUDs . 770 Implants (3) . 1,504 Implants (5) . 1,456 Injectables (1) . 49,780 Injectables (2) . 8,185 Combined Oral Contraceptives (COC) . 70,548 Emergency Contraception . 7,470 Total 82,464 476 3,388 3,760 5,533 4,148 1,364 5,039 467 106,640 68,693 397 3,696 3,760 5,533 3,833 1,367 4,706 374 92,357 60. Malawi (2) Started by MSI in 1987 MSI Condoms . 3,109,707 Emergency Contraception . 121,836 Misoprostol . 214,978 Total 31,097 7,615 17,915 56,627 25,904 6,092 — 31,996 61. Mali (1) Started by DKT in 2017 DKT Condoms . 739,680 Non-hormonal IUDs . 9,030 Injectables (3) . 46,100 Emergency Contraception . 195,620 MVA kits. 1,012 Misoprostol . 282,432 MA ‘Combipack’ . 4,686 Total 7,397 39,732 11,525 12,226 25,300 23,536 7,966 127,682 6,162 41,538 11,525 9,781 — — — 69,006 62. Mali (2) Started by an NGO called JIGI in 1991; Now managed by Momentum Private Health Delivery (MPHD) JIGI / MPHD Condoms . 726,300 Female Condoms . 100 Non-hormonal IUDs . 1,000 Implants (3) . 2,430 Injectables (3) . 410,302 Combined Oral Contraceptives (COC) . 353,004 Total 7,263 1 4,400 6,075 102,576 25,215 145,529 6,050 1 4,600 6,075 102,576 23,545 142,847 63. Mali (3) Started by MSI in 2008 MSI Condoms . 24,000 Combined Oral Contraceptives (COC) . 364 Emergency Contraception . 300 Misoprostol . 467,136 MA ‘Combipack’ . 2,201 Total 240 26 19 38,928 3,742 42,954 200 24 15 — — 239 64. Mauritania Started by DKT in 2021 DKT Condoms . 678,240 Emergency Contraception . 8,615 MVA kits. 45 Misoprostol . 91,320 MA ‘Combipack’ . 250 Total 6,782 538 1,125 7,610 425 16,481 5,650 431 — — — 6,080 16 PROGRAM INFORMATION SOURCE PRODUCT SALES CYPs (HISTORICAL) CYPs (USAID) 65. Mexico (1) Started by DKT in 2002; CYPs have been discounted DKT Condoms . 62,973,333 Female Condoms . 5,995 Hormonal IUDs . 12,324 Non-hormonal IUDs . 225,616 Implants (3) . 6,169 Injectables (1) . 42 Emergency Contraception . 1,631,593 MVA kits. 7,237 Aspirators . 4,899 Cannulae . 85,817 Misoprostol . 316,260 Mifepristone . 59,911 MA ‘Combipack’ . 2,561 Total 629,026 60 48,728 970,559 14,689 4 101,912 122,975 109,800 — 19,562 35,589 4,354 2,057,255 523,979 50 53,158 1,014,675 14,689 3 81,530 — — — — — — 1,688,083 66. Mexico (2) Started by MSI in 1999 MSI Condoms . 35,596 Non-hormonal IUDs . 1,072 Injectables (1) . 297 Misoprostol . 3,957 Mifepristone . 16,955 MA ‘Combipack’ . 58,961 Total 356 4,717 25 330 11,360 100,234 117,021 297 4,931 23 — — — 5,251 67. Mongolia Started by MSI in 2000 MSI Condoms . 5,805,835 Hormonal IUDs . 136 Non-hormonal IUDs . 40,184 Implants (3) . 10,748 Injectables (3) . 28,150 Combined Oral Contraceptives (COC) . 189,425 Emergency Contraception . 95,522 Misoprostol . 86,293 Mifepristone . 22,410 MA ‘Combipack’ . 43,096 Total 58,058 598 176,810 26,870 7,038 13,530 5,970 7,191 15,015 73,263 384,343 48,363 653 184,846 26,870 7,038 12,635 4,776 — — — 285,180 68. Mozambique Started by DKT in 2008; CYPs have been discounted DKT Condoms . 9,508,156 Female Condoms . 65,386 Non-hormonal IUDs . 7,626 Implants (3) . 7,974 Implants (5) . 29,619 Injectables (3) . 72,504 Combined Oral Contraceptives (COC) . 978,480 Emergency Contraception . 148,118 MVA kits. 29 Misoprostol . 180,012 MA ‘Combipack’ . 156,702 Total 95,082 654 33,554 16,185 112,552 18,126 68,659 9,157 725 14,876 254,629 624,200 79,203 545 35,080 16,185 112,552 18,126 64,114 7,326 — — — 333,130 69. Myanmar (1) Started by DKT in 2014; CYPs have been discounted DKT Condoms . 10,392,278 Non-hormonal IUDs . 20,321 Implants (4) . 72,740 Injectables (3) . 1,193,646 Combined Oral Contraceptives (COC) . 1,979,995 Emergency Contraception . 3,385,037 MVA kits. 602 Cannulae . 4,728 Misoprostol . 361,296 Total 103,436 76,124 197,152 293,173 141,150 211,475 15,050 — 30,108 1,067,669 86,162 79,585 — 293,173 131,806 169,180 — — — 759,906 70. Myanmar (2) Started by MSI in 1998 MSI Combined Oral Contraceptives (COC) . 5,838,410 Misoprostol . 63,400 Total 417,029 5,283 422,313 389,422 — 389,422 17 PROGRAM INFORMATION SOURCE PRODUCT SALES CYPs (HISTORICAL) CYPs (USAID) 71. Nepal (1) Started by MSI in 2002 MSI Condoms . 1,822,056 MA ‘Combipack’ . 63,128 Total 18,221 107,318 125,538 15,178 — 15,178 72. Nepal (2) Started in 1973 by Nepal Contraceptive Retail Sales (CRS) Nepal CRS Company Condoms . 463,764 Non-hormonal IUDs . 1,425 Implants (5) . 1,464 Injectables (3) . 969,912 Combined Oral Contraceptives (COC) . 2,120,614 Emergency Contraception . 1,065,970 Total 4,638 6,270 5,563 242,478 151,472 66,623 477,044 3,863 6,555 5,563 242,478 141,445 53,299 453,203 73. Niger (1) Started in 2007 ANIMAS- Sutura Condoms . 11,852,640 Injectables (3) . 33,701 Combined Oral Contraceptives (COC) . 1,021,080 Total 118,526 8,425 72,934 199,886 98,732 8,425 68,106 175,264 74. Niger (2) DKT Non-hormonal IUDs . 1,000 Emergency Contraception . 6,000 MVA kits. 300 Misoprostol . 19,200 MA ‘Combipack’ . 1,080 Total 4,400 375 7,500 1,600 1,836 15,711 4,600 300 — — — 4,900 75. Niger (3) Started by MSI in 2014 MSI Misoprostol . 10,000 Total 833 833 — — 76. Nigeria (1) Started by DKT in 2013; CYPs have been discounted DKT Condoms . 127,109,952 Hormonal IUDs . 1,112 Non-hormonal IUDs . 621,860 Injectables (3) . 743,280 Combined Oral Contraceptives (COC) . 5,381,595 Emergency Contraception . 2,410,540 MVA kits. 29,654 Misoprostol . 8,208,744 MA ‘Combipack’ . 385,615 Diaphragm . 1,113 MVA/single value . 8,726 Total 1,270,698 4,893 1,735,514 183,570 384,280 150,659 667,913 679,810 654,398 1,113 218,150 5,950,997 1,058,491 5,338 1,814,401 183,570 358,841 120,527 — — — 1,113 — 3,542,281 77. Nigeria (2) Started by MSI in 2009 MSI Condoms . 6,824,982 Emergency Contraception . 780,631 Misoprostol . 1,793,757 MA ‘Combipack’ . 216,871 Total 68,250 48,789 149,480 368,681 635,200 56,852 39,032 — — 95,884 78. Pakistan (1) Started by DKT in 2012; CYPs have been discounted DKT Condoms . 68,616,211 Female Condoms . 15,761 Non-hormonal IUDs . 978,096 Injectables (1) . 14,811 Injectables (3) . 631,942 Combined Oral Contraceptives (COC) . 1,620,359 Emergency Contraception . 369,325 MVA kits. 962 Misoprostol . 6,490,890 Total 535,890 105 4,120,912 1,234 147,563 114,133 21,192 20,350 540,491 5,501,870 446,397 88 4,308,227 1,140 147,563 106,577 16,954 — — 5,026,945 79. Pakistan (2) Started by MSI in 2003 MSI Condoms . 1,814,976 Misoprostol . 96,750 Total 18,150 8,063 26,212 15,119 — 15,119 18 PROGRAM INFORMATION SOURCE PRODUCT SALES CYPs (HISTORICAL) CYPs (USAID) 80. Panama Started by DKT in 2017 DKT Condoms . 391,700 Non-hormonal IUDs . 1,420 MVA kits. 3 Aspirators . 3,000 Cannulae . 14,200 Total 3,917 6,248 75 75,000 — 85,240 3,263 6,532 — — — 9,795 81. Paraguay Started by DKT in 2017 DKT Condoms . 212,809 Female Condoms . 2,345 Non-hormonal IUDs . 3,245 Injectables (3) . 5,610 Combined Oral Contraceptives (COC) . 1,200 Emergency Contraception . 2,270 Aspirators . 310 Cannulae . 1,322 Diaphragm . 171 Total 2,128 23 14,278 1,403 86 142 7,750 — 171 25,981 1,773 20 14,927 1,403 80 114 — — 171 18,486 82. Philippines Started by DKT in 1990; CYPs have been discounted DKT Condoms . 45,799,378 Non-hormonal IUDs . 98,151 Injectables (3) . 1,384,487 Combined Oral Contraceptives (COC) . 33,299,483 MVA kits. 3,349 Total 457,982 251,590 346,016 2,378,498 83,725 3,517,810 381,499 263,026 346,016 2,221,041 — 3,211,582 83. Rwanda Started by PSI in 1993. Managed by PSI Rwanda and SFH Rwanda SFH - PSI Condoms . 6,528,629 Injectables (1) . 22,265 Combined Oral Contraceptives (COC) . 146,969 Emergency Contraception . 21,816 Total 65,286 1,855 10,498 1,364 79,003 54,383 1,714 9,803 1,091 66,992 84. Senegal (1) Started by DKT in 2016; CYPs have been discounted DKT Condoms . 5,836,764 Non-hormonal IUDs . 15,225 Injectables (3) . 5,000 Emergency Contraception . 26,545 MVA kits. 1,020 Misoprostol . 335,360 Total 58,368 66,990 1,250 1,659 21,325 27,947 177,538 48,620 70,035 1,250 1,327 — — 121,232 85. Senegal (2) Started by MSI in 2011 MSI Condoms . 384,840 Emergency Contraception . 4,280 Misoprostol . 205,230 Total 3,848 268 17,103 21,218 36 214 — 250 86. Sierra Leone (1) Started by DKT in 2018; CYPs have been discounted DKT Condoms . 1,110,660 Non-hormonal IUDs . 6,640 Implants (3) . 3,460 Injectables (3) . 94,974 Combined Oral Contraceptives (COC) . 383,826 Emergency Contraception . 404,324 MVA kits. 1,502 Misoprostol . 256,504 MA ‘Combipack’ . 23,571 Total 11,107 29,216 8,650 23,744 27,416 25,270 36,988 21,375 40,071 223,836 9,252 30,544 8,650 23,744 25,601 20,216 — — — 118,007 87. Sierra Leone (2) Started by MSI in 1986 MSI Condoms . 115,920 Combined Oral Contraceptives (COC) . 22,000 Emergency Contraception . 215,500 Misoprostol . 127,800 MA ‘Combipack’ . 27,910 Total 1,159 1,571 13,469 10,650 47,447 74,296 966 1,467 10,775 — — 13,208 19 PROGRAM INFORMATION SOURCE PRODUCT SALES CYPs (HISTORICAL) CYPs (USAID) 88. Sierra Leone (3) Started by SLaDA (Sierra Leone Social Marketing and Development Agency) in 2013 SLaDA Condoms . 18,000 Total 180 180 150 150 89. Sri Lanka (1) Started by PSI and IPPF in 1973; now managed by Family Planning Association of Sri Lanka FPA Sri Lanka Condoms . 11,466,282 Non-hormonal IUDs . 1,718 Implants (5) . 2,649 Injectables (3) . 169,511 Combined Oral Contraceptives (COC) . 1,692,244 Emergency Contraception . 1,838,367 Total 114,663 7,559 10,066 42,378 120,875 114,898 410,438 95,514 7,903 10,066 42,378 112,873 91,918 360,652 90. Sri Lanka (2) Started by MSI in 1983 MSI Condoms . 2,993,034 Combined Oral Contraceptives (COC) . 22,347 Emergency Contraception . 18,533 Total 29,930 1,596 1,158 32,685 24,932 1,491 927 27,349 91. South Sudan Started by DKT in 2021 DKT Condoms . 190,080 Combined Oral Contraceptives (COC) . 10,000 Emergency Contraception . 44,800 MVA kits. 10 MA ‘Combipack’ . 360 Total 1,901 714 2,800 250 612 6,277 1,583 667 2,240 — — 4,490 92. Sudan DKT Condoms . 242,025 Non-hormonal IUDs . 2,508 MVA kits. 287 Total 2,420 11,035 7,175 20,630 2,016 11,537 — 13,553 93. Tanzania (1) Started by DKT in 2015; CYPs have been discounted DKT Condoms . 4,508,352 Non-hormonal IUDs . 2,028 Implants (5) . 120 Injectables (3) . 50 Combined Oral Contraceptives (COC) . 1,574,586 Emergency Contraception . 645,678 MVA kits. 689 Misoprostol . 1,460,240 MA ‘Combipack’ . 1,510 Total 45,084 8,923 456 13 112,470 40,355 17,225 121,682 2,567 348,774 37,555 9,329 456 13 105,025 32,284 — — — 184,661 94. Tanzania (2) Started by MSI in 1989 MSI Condoms . 2,660,760 Emergency Contraception . 94,800 Misoprostol . 123,400 Total 26,608 5,925 10,283 42,816 22,164 4,740 — 26,904 95. Tanzania (3) Started by T-MARC in 2004 T-MARC Combined Oral Contraceptives (COC) . 436,752 Progestin-only Pills (POP) . 54,550 Total 31,197 3,896 35,093 29,131 4,544 33,675 96. Thailand Started by DKT in 2008 DKT Non-hormonal IUDs . 5,713 MVA/single value . 450 MVA kits. 1,081 Cannulae . 5,141 MA ‘Combipack’ . 6,669 Total 25,137 11,250 27,025 — 11,337 74,750 26,280 — — — — 26,280 20 PROGRAM INFORMATION SOURCE PRODUCT SALES CYPs (HISTORICAL) CYPs (USAID) 97. Togo Started by DKT in 2008 DKT Condoms . 1,909,080 Non-hormonal IUDs . 1,850 Injectables (3) . 1,400 Emergency Contraception . 181,120 MVA kits. 150 Misoprostol . 352,800 MA ‘Combipack’ . 10,080 Total 19,091 8,140 350 11,320 3,750 29,400 17,136 89,187 15,903 8,510 350 9,056 — — — 33,819 98. Turkey Started by DKT in 2008 DKT Condoms . 4,729,200 Non-hormonal IUDs . 63,800 Emergency Contraception . 291,282 Total 47,292 280,720 18,205 346,217 39,394 293,480 14,564 347,438 99. Uganda (1) Started by DKT in 2017; CYPs have been discounted DKT Condoms . 10,690,617 Non-hormonal IUDs . 3,049 Implants (3) . 1,668 Injectables (3) . 164,977 Combined Oral Contraceptives (COC) . 534,040 Emergency Contraception . 3,184,829 MVA kits. 294 Misoprostol . 487,572 MA ‘Combipack’ . 106,475 Total 106,906 13,416 4,170 41,244 38,146 199,052 7,350 40,631 178,997 629,912 89,053 14,025 4,170 41,244 35,620 159,241 — — — 343,354 100. Uganda (2 ) Started by MSI in 1997 MSI Hormonal IUDs . 2 Non-hormonal IUDs . 4 Combined Oral Contraceptives (COC) . 383,627 Emergency Contraception . 541,402 Misoprostol . 1,325,940 MA ‘Combipack’ . 49,787 Total 9 18 27,402 33,838 110,495 84,638 256,399 10 18 25,588 27,070 — — 52,686 101. Uruguay Started by DKT in 2016 DKT Condoms . 1,105,599 Non-hormonal IUDs . 677 Aspirators . 46 Cannulae . 369 Total 11,056 2,979 1,150 — 15,185 9,210 3,114 — — 12,324 102. Venezuela DKT Condoms . 446,420 Hormonal IUDs . 565 Non-hormonal IUDs . 800 Implants (3) . 750 Emergency Contraception .14,000 MVA .100 Total 4,464 2,486 3,520 1,875 875 2,500 15,720 3,719 2,712 3,680 1,875 700 — 12,686 103. Viet Nam (1) Started by DKT in 1993; CYPs have been discounted DKT Condoms . 8,549,874 Non-hormonal IUDs . 270,968 Combined Oral Contraceptives (COC) . 13,541,478 Emergency Contraception . 186,900 MVA kits. 1,400 Cannulae . 35,082 MVA/single value . 2,400 Total 85,499 1,040,459 967,248 11,681 35,000 — 60,000 2,199,888 71,220 1,087,753 903,217 9,345 — — — 2,071,535 21 PROGRAM INFORMATION SOURCE PRODUCT SALES CYPs (HISTORICAL) CYPs (USAID) 104. Viet Nam (2) Started by MSI in 1989 MSI Condoms . 2,742 Non-hormonal IUDs . 108,067 Implants (3) . 58 Injectables (3) . 127,310 Emergency Contraception . 42,671 Misoprostol . 3,061,960 Mifepristone . 450,179 MA ‘Combipack’ . 47,999 Total 27 475,495 145 31,828 2,667 255,163 301,620 81,598 1,148,543 23 497,108 145 31,828 2,134 — — — 531,237 105. Yemen Started by MSI in 2001 MSI Condoms . 4,766,157 Non-hormonal IUDs . 135,000 Implants (3) . 21,273 Injectables (3) . 350,000 Combined Oral Contraceptives (COC) . 2,059,309 Misoprostol . 88,693 Total 47,662 594,000 53,183 87,500 147,094 7,391 936,829 39,702 621,000 53,183 87,500 137,356 — 938,740 106. Zambia (1) DKT Injectables (3) . 5,000 Emergency Contraception . 50,000 MA ‘Combipack’ . 20,000 Total 1,250 3,125 34,000 38,375 1,250 2,500 — 3,750 107. Zambia (2) Started by MSI in 2007 MSI Combined Oral Contraceptives (COC) . 116,810 Emergency Contraception . 105,144 Misoprostol . 231,040 MA ‘Combipack’ . 21,782 Total 8,344 6,572 19,253 37,029 71,198 7,791 5,257 — — 5,257 108. Zambia (3) Started by USAID Zambia Accessible Markets for Health in 2021 USAID Condoms . 10,149,200 Combined Oral Contraceptives (COC) . 95,600 Total 101,492 6,829 108,321 84,543 6,377 90,919 109. Zimbabwe (1) MSI Condoms . 2,270 Non-hormonal IUDs . 1,094 Implants (3) . 76 Emergency Contraception . 175,346 Misoprostol . 61,320 MA ‘Combipack’ . 2,150 Total 23 4,814 190 10,959 5,110 3,655 24,750 19 5,032 190 8,767 — — 14,009 110. Zimbabwe (2) Started by PSH - Population Solutions for Health PSH - PSI Condoms . 7,731,690 Total 77,317 77,317 64,405 64,405 GRAND TOTAL 81,659,976 60,922,449 22 Annex 1: A User-Informed Design Process to Inform the Future of the CSM Report In the year ahead, RHSC will implement a series of user-informed design activities to collect feedback from the RH community around the ways in which the report is currently used, challenges that members have faced with the report, and opportunities to improve or expand the report’s utility. These activities will build on the initial consultations carried out in 2023, described further in the Director’s Note at the start of this report. To implement these activities, RHSC will continue to seek guidance from the Advisory Group (AG). From the early consultations, and through initial discussions with the AG, we have identified five overarching themes that we will explore through a user-informed design process in the year ahead: 1. Data Definitions and Structure: What data definitions within the report need the most attention or additional clarity? And what modifications to the data hierarchy, categories, and mapping is needed to ensure complementarity across community data sets. 2. Data Automation: What type of data automation is needed – both in reporting and use of the report – and in what format? 3. Data Granularity: Where is additional data granularity needed within the report and what purpose would it serve? 4. Report Analyses: What types of data analysis or visualization does the community wish to see in the report, and in what format? 5. Data Clarity & Transparency: Where is additional data clarity or transparency needed within the report and what are the current concerns? RHSC also recognizes that many of the priority areas outlined above are not unique to the CSM Report, but rather, relevant across the SRH data ecosystem. To that end, RHSC will also facilitate broader conversations around data needs within our community and ensure alignment with other RHSC-produced and managed data reports, tools, and platforms. Over the course of the next year, we have a plan guided by the AG to undertake this user-informed design around these five thematic areas: data definitions, data automation, data granularity, report analyses, and data clarity & transparency. To do this, RHSC will implement several different user-informed design activities, including survey tools to collect feedback from across its diverse membership, focus group discussions with members around emerging issues, and where needed, key informant interviews to better understand specific use cases and needs. All of these activities will be guided by the AG, and the AG will continue to convene regularly to make recommendations rooted in the member feedback that is collected. MEMBER SURVEY To begin this process, RHSC has developed a MEMBER SURVEY which has been disseminated alongside the 2023 CSM Report. This survey asks a series of questions around the current use of the CSM Report, reflections on the changes included for the 2023 CSM Report, and around the five priority areas. As the user-informed design activities are implemented in the year ahead, RHSC will continue to disseminate calls for participation widely among its membership. Members are also encouraged to reach out to us via csmreport@rhsupplies.org for any additional feedback. https://www.surveymonkey.com/r/2023CSMSURVEY mailto:csmreport%40rhsupplies.org?subject= 23 Annex 2: Acknowledgments The development and publication of the 2023 CSM Report would not have been possible without the thought partnership, leadership, and input from a number of RHSC Secretariat Staff and Members. RHSC would like to thank the Secretariat Team that worked to pull this report together, including: Reina Jara Barrientos, Sarah Webb, Julia White, Ntindah Luembe, Lucian Alexe, Hannah Pandian, and Martyn Smith. We would also like to thank the many partners who provided valuable input throughout this process, including ongoing discussions and consultations with DKT International, Marie Stopes International, Population Services International, and Avenir Health. RHSC is also grateful to the many SMOs who reported their sales data in the 2023 CSM Report, without whom this report would not be possible. Finally, we would like to sincerely thank the CSM Report AG, who guided us throughout this process and continues to provide important recommendations as we move forward. Thank you to our AG Members: Abi Winskell, PSI Agnes Chidanyika, UNFPA Andrea Bare, USAID Anne Kuster, CHAI Chris Jones, Jones Global Insights Deniz Kayabas, MSI Eleni Han, CHAI Eloise Cowan, DKT International Gibran Abidin, PT Tunggal Idaman Abdi Gladys Tetteh-Yeboah, USAID Ghana Glenn Milano, USAID Jens Rasmussen, Mission Pharma Marcie Cook, PSI Matthea Roemer, MSI Michelle Weinberger, Avenir Health Samora Michael Mensah, DKT Ghana Sydney Sauter, Tulane University, School of Public Health & Tropical Medicine Teymur Seyidov, UNFPA Courtesy of the Reproductive Health Supplies Coalition 455 Massachusetts Avenue NW, Suite 1000, Washington, DC 20001 � �� � � THE REPRODUCTIVE HEALTH SUPPLIES COALITION The Reproductive Health Supplies Coalition is the world’s largest network of reproductive health (RH) supplies organizations. Formed in 2004, we are a partnership of nearly 500 public entities, private corporations, and NGOs working so that everyone in low- and middle-income countries (LMICs) can access and use a�ordable, high-quality RH supplies. https://www.linkedin.com/company/reproductive-health-supplies-coalition/ https://www.facebook.com/rhsupplies https://twitter.com/rh_supplies https://www.youtube.com/@rhsupplies https://medium.com/its-about-supplies

View the publication